Trials / Unknown
UnknownNCT01119534
Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin
Comparative Efficacy of the Suppository Composed by Guaiacol, Eucalyptol, Menthol and Camphor Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 270 (estimated)
- Sponsor
- Azidus Brasil · Industry
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to reduce the signs and symptoms related to upper respiratory infections in a manner equivalent (not inferior) to medicine used as a comparator in this study and higher than the suppository containing only guaiacol concentration of 12.5 mg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Guaiacol, eucalyptol, menthol and camphor suppository | 2 times per day |
| DRUG | guaiacol suppository | 2 times per day |
| DRUG | Guaifenesin syrup | 4.19 mL - 4 in 4 hours |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-10-01
- Completion
- 2011-12-01
- First posted
- 2010-05-07
- Last updated
- 2011-01-28
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01119534. Inclusion in this directory is not an endorsement.